Efficiency of hepatocyte pretreatment with coenzyme Q10 against statin toxicity

Open access

Summary

Statins are potent cholesterol-lowering drugs that can have serious adverse effects on the muscles and liver. The aim of our in vitro study was to establish the protective effect of coenzyme Q10 (CoQ10, in its optimal dose of 200 μmol L-1) against cytotoxicity induced by atorvastatin, simvastatin, and lovastatin in isolated rat hepatocytes by observing parameters such as cell death, reactive oxygen species formation, lipid peroxidation, mitochondrial membrane potential, and cellular reduced and oxidised glutathione content. Our findings have shown that pretreatment with CoQ10 was effective in reducing the toxic effects of statins in rat hepatocytes. This work demonstrates that the addition of CoQ10 to statin treatment regimens may protect hepatocytes (and also other types of cells) from statin-induced injuries and alleviate their side effects.

1. Kashani A, Phillips CO, Foody JM, Wang Y, Mangalmurti S, Ko DT, Krumholz HM. Risks associated with statin therapy: a systematic overview of randomized clinical trials.Circulat ion 2006;114:2788-97. doi: 10.1161/ CIRCULATIONAHA.106.624890

2. Kubota T, Fujisaki K, Itoh Y, Yano T, Sendo T, Oishi R.Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors. Biochem Pharmacol 2004;67:2175-86. PMID: 15163549

3. Abdoli N, Heidari R, Azarmi Y, Eghbal MA. Mechanisms of the statins cytotoxicity in freshly isolated rat hepatocytes. J Biochem Mol Toxicol 2013;27:287-94. doi: 10.1002/ jbt.21485

4. Björnsson E, Jacobsen EI, Kalaitzakis E. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol 2012;56:374-80. doi: 10.1016/j. jhep.2011.07.023

5. Ellesat KS, Tollefsen KE, Asberg A, Thomas KV, Hylland K. Cytotoxicity of atorvastatin and simvastatin on primary rainbow trout (Oncorhynchus mykiss) hepatocytes. Toxicol In Vitro 2010;24:1610-8. doi: 10.1016/j.tiv.2010.06.006

6. Potgieter M, Pretorius E, Pepper MS. Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation. Nutr Rev 2013;71:180-8. doi: 10.1111/ nure.12011

7. Deichmann R, Lavie C, Andrews S. Coenzyme Q10 and statin-induced mitochondrial dysfunction. Ochsner J 2010;10:16-21. PMCID: PMC3096178

8. Martin SB, Cenini G, Barone E, Dowling AL, Mancuso C, Butterfield DA, Murphy MP, Head E. Coenzyme Q10 and cognition in atorvastatin treated dogs. Neurosci Lett 2011;501:92-5. doi: 10.1016/j.neulet.2011.06.054

9. Abadi A, Crane JD, Ogborn D, Hettinga B, Akhtar M, Stokl A, Macneil L, Safdar A, Tarnopolsky M. Supplementation with alpha-lipoic acid, CoQ10, and vitamin E augments running performance and mitochondrial function in female mice. PLoS One 2013;8:e60722.

10. Caso G, Kelly P, McNurlan MA, Lawson WE. Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins. Am J Cardiol 2007;99:1409-12. PMID: 17493470

11. Mas E, Mori TA. Coenzyme Q10 and statin myalgia: what is the evidence? Curr Atheroscler Rep 2010;12:407-13. doi: 10.1007/s11883-010-0134-3

12. Vidyarthi M, Jacob P, Chowdhury TA. Oral use of “Low and Slow” rosuvastatin with co-enzyme Q10 in patients with statin-induced myalgia: retrospective case review. Indian J Endocrinol Metab 2012;16(Suppl 2): S498-500. doi: 10.4103/2230-8210.104144

13. Young JM, Florkowski CM, Molyneux SL, McEwan RG, Frampton CM, George PM, Scott RS. Effect of coenzyme Q10 supplementation on simvastatin-induced myalgia. Am J Cardiol 2007;100:1400-3. PMID: 17950797

14. Vaughan Ms RA, Garcia-Smith R, Bisoffi M, Conn CA, Trujillo KA. Ubiquinol rescues simvastatin-suppression of mitochondrial content, function and metabolism: implications for statin-induced rhabdomyolysis. Eur J Pharmacol 2013;711:1-9. doi: 10.1016/j.ejphar.2013.04.009

15. González R, Ferrín G, Hidalgo AB, Ranchal I, López-Cillero P, Santos-Gónzalez M, López-Lluch G, Briceño J, Gómez MA, Poyato A, Villalba JM, Navas P, de la Mata M, Muntané J. N-acetylcysteine, coenzyme Q10 and superoxide dismutase mimetic prevent mitochondrial cell dysfunction and cell death induced by d-galactosamine in primary culture of human hepatocytes. Chem Biol Interact 2009;181:95-106. doi: 10.1016/j.cbi.2009.06.003

16. Moldéus P, Thor H, Högberg J, Orrenius S. Drug metabolism and toxicity studies in isolated rat liver cells. International congress series no. 417. Amsterdam: Excerpta medica; New York: distributed by Elsevier North-Holland; 1977. p. 75-84.

17. Heidari R, Babaei H, Eghbal MA. Cytoprotective effects of taurine against toxicity induced by isoniazid and hydrazine in isolated rat hepatocytes. Arh Hig Rada Toksikol 2013;64:201-9. doi: 10.2478/10004-1254-64-2013-2297

18. Björkhem-Bergman L, Lindh JD, Bergman P. What is a relevant statin concentration in cell experiments claiming pleiotropic effects? Br J Clin Pharmacol 2011;72:164-5. doi: 10.1111/j.1365-2125.2011.03907.x

19. O’Brien PJ, Chan K, Silber PM. Human and animal hepatocytes in vitro with extrapolation in vivo. Chem Biol Interact 2004;150:97-114. PMID: 15522264

20. Delaney S. Accelerated Cytotoxicity Mechanism Screening of 4-Aminobiphenyl in an in vitro Hepatocyte Inflammation Model. [PhD thesis]. Toronto: Graduate Department of Pharmaceutical Sciences, University of Toronto; 2011.

21. Heidari R, Babaei H, Eghbal MA. Amodiaquine-induced toxicity in isolated rat hepatocytes and the cytoprotective effects of taurine and/or N-acetyl cysteine. Res Pharm Sci 2014;9:97-105.

22. Heidari R, Babaei H, Eghbal MA. Ameliorative effects of taurine against methimazole-induced cytotoxicity in isolated rat hepatocytes. Sci Pharm 2012;80:987-99. doi: 10.3797/ scipharm.1205-16

23. Rahman I, Kode A, Biswas SK. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nature Protocols 2006;1:3159-65. PMID: 17406579

24. Heidari R, Babaei H, Eghbal M. Mechanisms of methimazole cytotoxicity in isolated rat hepatocytes. Drug Chem Toxicol 2013;36:403-11. doi: 10.3109/01480545.2012.749272

25. Eghbal MA, Pennefather PS, O’Brien PJ. H2S cytotoxicity mechanism involves reactive oxygen species formation and mitochondrial depolarisation. Toxicology 2004;203:69-76.PMID: 15363583

26. Benzie IF. Lipid peroxidation: a review of causes, consequences, measurement and dietary influences. Int J Food Sci Nutr 1996;47:233-61. PMID: 8735779

27. Muraki A, Miyashita K, Mitsuishi M, Tamaki M, Tanaka K, Itoh H. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.J Appl Physiol 2012;113:479-86. doi: 10.1152/ japplphysiol.01362.2011

28. Bełtowski J, Wójcicka G, Jamroz-Wiśniewska A. Adverse effects of statins - mechanisms and consequences. Curr Drug Saf 2009;4:209-28. PMID: 19534648

29. La Guardia PG, Alberici LC, Ravagnani FG, Catharino RR, Vercesi AE. Protection of rat skeletal muscle fibers by either L-carnitine or coenzyme Q10 against statins toxicity mediated by mitochondrial reactive oxygen generation. Front Physiol 2013;4:103. doi: 10.3389/fphys.2013.00103

30. Bentinger M, Brismar K, Dallner G. The antioxidant role of coenzyme Q. Mitochondrion 2007;7(Suppl):S41-50. PMID: 17482888

31. Villalba JM, Navarro F, Gómez-Díaz C, Arroyo A, Bello RI, Navas P. Role of cytochrome b5 reductase on the antioxidant function of coenzyme Q in the plasma membrane. Mol Aspects Med 1997;18(Suppl):S7-13. PMID: 9266501

32. Moreira PI, Santos MS, Sena C, Nunes E, Seiça R, Oliveira CR. CoQ10 therapy attenuates amyloid β-peptide toxicity in brain mitochondria isolated from aged diabetic rats. Exp Neurol 2005;196:112-9. doi: 10.1016/j.expneurol.2005.07.012

33. Ali SA, Faddah L, Abdel-Baky A, Bayoumi A. Protective effect of l-carnitine and coenzyme Q10 on CCL4-induced liver injury in rats. Sci Pharm 2010;78:881-96. doi: 10.3797/ scipharm.1006-02

34. Gebhardt R, Hengstler JG, Müller D, Glöckner R, Buenning P, Laube B, Schmelzer E, Ullrich M, Utesch D, Hewitt N, Ringel M, Hilz BR, Bader A, Langsch A, Koose T, Burger HJ, Maas J, Oesch F. New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures. Drug Metab Rev 2003;35:145-213. PMID: 12959414

Archives of Industrial Hygiene and Toxicology

The Journal of Institute for Medical Research and Occupational Health

Journal Information


IMPACT FACTOR 2017: 1.117
5-year IMPACT FACTOR: 1.335



CiteScore 2017: 1.24

SCImago Journal Rank (SJR) 2017: 0.341
Source Normalized Impact per Paper (SNIP) 2017: 0.494

Cited By

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 227 224 11
PDF Downloads 98 96 4